Your SlideShare is downloading. ×
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends

313

Published on

A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization.This report primarily focuses on bacterial nosocomial infections with some mention of viral …

A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization.This report primarily focuses on bacterial nosocomial infections with some mention of viral infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medical considerations and on market considerations.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
313
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,Treatments, Key Competitors and TrendsPublished: July 2011No. of Pages: 150Price: $3995A hospital-acquired infection (HAI)is a new infection that develops in a patient duringhospitalization. It is usually defined as an infection that is identified at least forty-eight toseventy-two hours following admission, so infections incubating, but not clinically apparent,at admission are excluded. This type of infection is also known as a nosocomial infection (ormore generically healthcare-associated infections).The following market data is provided in this report:• Hospital-Acquired Infections Diagnostics Markets• Forecast for HAI Diagnostics to 2015• HAI Tests on the Market• Market for Diagnostics by Infection Type (C. Diff., MRSA, Pneumonia, Other)• Molecular HAI Market vs. Conventional HAI Market, Present and in 2015• Geographic Breakdown of Testing (U.S., Europe, Asia, ROW)• New Hospital Infection Product Testing Products in the Market• Company Profiles• Treatment Products on the Market, HAI Antibiotic market Size and ForecastBoth diagnostics and treatment segments have unique circumstances for growth which arediscussed in detail in the report. Worldwide, both segments combined are worth more than$9 billion for 2010 with 2015 sales expected to reach $10.3 billion. The market has shownan increase of 3% annually with sales increasing from $7.9 billion in 2005. Although thetreatment segment will continue to struggle to maintain growth, the testing segment willoffset declines beginning in 2012.Browse All: Biotechnology Market ResearchThis report primarily focuses on bacterial nosocomial infections with some mention of viralinfections. The major consideration is given to bacterial nosocomial infections because a)they are the most frequent type of infections spread in the hospital setting, and b) the
  • 2. practical aspects of diagnosis and therapy are more meaningful based both on medicalconsiderations and on market considerations.Some of the issues discussed in this report include:• Development of Potential Life-Saving Products• Development of Fast Testing Systems• Growing Drug Resistance• Development of Better Pharmacodiagnostics• Market Opportunity and Growth Rates Expected in Diagnostics versus Treatment• Hospital Procedures for Use of Testing and Antibiotics• Attention to Special Population Issues• Demographics and Epidemiology• New Government Guidelines and Requirements for Preventing Infection• Focus on Alliances and PartnershipsMarket analysis in this report considers primarily the epidemiological considerations and thesize of patient groups both in the United States and globally, where available. We haveaccumulated the most recent data available, understanding that virtually no organizationdoes extensive studies on these applications on a regular basis. Many studies are highlylocalized and may only apply to a community, state or country (more often countries thatare not a part of the major markets for nosocomial diagnostic and therapeutic products). Inmany instances, we have had to draw from broader epidemiologic data, that is, on data thatreach outside of the hospital environment in order to try and construct a picture of thenosocomial testing and treatment needs.The primary focus of this report is on the bacterial form of nosocomial infections, and thosewith significant impact on the hospital setting and markets. In looking at these infections,we consider the diagnostic and therapeutic technologies that are currently available andattempt to project trends in these product areas. To some extent, we are limited by theactivity of the industries associated with the diagnosis and treatment of these infections. Forthe most part, these activities are limited and the advanced technologies seen in otherareas of medical application are not necessarily present in terms of microbiology.The analysis presented in this report is based on data from a combination of company,government, industry, institutional and private sources. It includes information fromextensive literature reviews and discussions with experts in the field, includingmicrobiologists, pathologists, hospital authorities, research scientists, business developmentmanagers and marketing managers.TABLE OF CONTENTSCHAPTER ONE:EXECUTIVE SUMMARYOverview
  • 3. Infection Control SummaryScope and MethodologyTotal Size and Growth of the MarketIssues and Trends Affecting MarketMolecular Testing vs. Conventional TestingLeading CompetitorsCHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDSOverviewIntroduction to PathogensClassification of Antibacterial OrganismsCommon Hospital (nosocomial) InfectionsDescription of InfectionsAcinetobacter BaumanniiClostridium DifficileGastroenteritisHospital-Acquired Pneumonia (HAP)Pseudomonas AeruginosaStaphylococcus Aureus/Methicillin-Resistant Staphylococcus AureusStenotrophomonas MaltophiliaTuberculosisUrinary Tract InfectionsVancomycin-Resistant EnterococcusHospital Units and Infection RisksBurn UnitsIntensive Care UnitsEmergency DepartmentsPrinciples of Anti-bacterial TherapyInfecting OrganismAntibiotic Sensitivity TestingSite of InfectionHost Defenses and Organ FunctionAntibiotic PharmacokineticsMonitoring TherapyGeneral Infection StatisticsNosocomial Infection StatisticsPopulations at Risk for InfectionDemographics of the WorldInfections and Drug ResistanceCauses of Drug ResistanceAntibiotic AbuseAntibiotic Use in AgricultureDrug Resistance in Select PopulationsChildren
  • 4. The ElderlyCompromised IndividualsMeasures for Reducing ResistanceAntibiotic CyclingAntibiotic EducationScreening Hospitalized patientsThe American Recovery and Reinvestment Act of 2009Financial Impact of Hospital InfectionsState Level Case Study of HAI Admissions and ReadmissionsManufacturer and Marketer TrendsTrends in Partnerships and AlliancesDevelopers TrendsCHAPTER THREE: HOSPITAL INFECTION DIAGNOSTICSOverviewMethods of TransmissionAirborneContactDirect-Contact TransmissionIndirect-Contact TransmissionDropletVehiclePrevention MeasuresTestingDrug-Resistance/Susceptibility TestingGenotypic MethodsDNA SequencingSolid-phase Hybridization TechniquesMicroarraysReal-time Polymerase Chain Reaction TechniquesPhenotypic MethodsPhage-based AssaysColorimetric MethodsThe Nitrate Reductase AssayNosocomial Disease TestingAcinetobacter BaumanniiClostridium DifficileHospital-Acquired PneumoniaVentilator-Associated PneumoniaPseudomonas AeruginosaStaphylococcus AureusTuberculosisUrinary Tract InfectionsNew Developments
  • 5. Market OverviewTotal Market Size and ForecastHAI Testing by Infection TypeHospital Infection Testing Market by Geographical RegionMolecular Testing vs. Conventional Testing.Market and Forecast for Molecular HAICompetitors in HAI TestingCHAPTER FOUR: TREATING HOSPITAL INFECTIONSOverviewTreatment GuidelinesClostridium DifficileGastroenteritisHospital-Acquired PneumoniaVentilator-associated PneumoniaPseudomonas AeruginosaStaphylococcus AureusStenotrophomonas maltophiliaTuberculosisUrinary Tract InfectionsRecent Drug ApprovalsMarket OverviewCHAPTER FIVE: MARKET SUMMARYMarket ConsiderationsMarket OverviewRegional Breakdown of MarketCompetitive SummaryCHAPTER SIX: COMPANY PROFILESIntroductionAbbott LaboratoriesAdvanDx, Inc.AlereAstraZenecaBayer Healthcare Pharmaceuticals (Bayer Schering Pharma) v Becton, DickinsonCepheidCubist PharmaceuticalsDaiichi SankyoDiatherix Laboratories Inc.Gen-Probe Inc.GlaxoSmithKlineJohnson & JohnsonMerck & Co.
  • 6. Meridian Bioscience, Inc.PfizerRocheSeegene, Inc.APPENDIX:LIST OF MAJOR PROVIDERSLIST OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARYTable 1-2: The Global Market for Hospital Infections by Product Segment (Diagnostics,Treatment), 2005-2015Figure 1-1: The Global Market for Hospital Infections 2005-2015Figure 1-2: Growth Rate - HAI Diagnostic Market vs. HAI Treatment MarketTable 1-3: MRSA Risk and Testing PriorityCHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDSTable 2-1: Antibiotics with Difficult PenetrationTable 2-2: Common Nosocomial InfectionsTable 2-3: Risk Factors for M. tuberculosisTable 2-4: Common ICU InfectionsTable 2-5: Estimated World and U.S. Incidence of Bacterial InfectionsFigure 2-1: Estimated World and U.S. Incidence of Bacterial InfectionsFigure 2-2: U.S. Hospital Admissions, Percent Acquiring HAIsTable 2-6: World Population at Risk for Serious Bacterial Infections, Secondary to ChronicDiseases by Selected Geographical Region (World, U.S., Europe), 2010Figure 2-3: World Population at Risk for Serious Bacterial Infections, Secondary to ChronicDiseases by Selected Geographical Region, 2010Table 2-4: Estimated World Population by Age and Geographical Region, 2010Figure 2-4: Estimated World Population by Age and Geographical Region, 2010Table 2-5: Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2009Table 2-6: Pennsylvania State Analysis of HAIs, 2009CHAPTER THREE: HOSPITAL INFECTION DIAGNOSTICSTable 3-1: CDC Healthcare Setting GuidelinesTable 3-2: MRSA Risk and Testing PriorityTable 3-3: Recent Approvals for Hospital Infection Testing (Product, Company, Descriptionof Test, Approved Regions)Table 3-4: New Developments, Hospital Infection Testing (Developer, Description, Status,Indication)Table 3-5: The World Market for Hospital Infection Testing/Diagnostics 2005-2015(Revenues, Percent Change)Figure 3-1: The World Market for Hospital Infection Testing/Diagnostics 2005-2015
  • 7. Figure 3-2: Distribution of Revenues for HAI Testing by Infection Type, 2010 Estimates(MRSA, Cdiff, Other HAIs)Table 3-6: The World Market for Hospital Infection Testing/Diagnostics Estimated ProductsSales by Geographic Region (US, Europe, ROW) 2005-2015Figure 3-3: The World Market for Hospital Infection Testing/Diagnostics Estimated ProductSales by Geographic Region (US, Europe, ROW) 2005-2015Table 3-7: Detection Time for MRSA by Screening Method (Test Type, Turnaround Time,Average Cost)Figure 3-4: Molecular vs. Conventional Diagnostic Market for HAIs in 2010 and Projected to2015Table 3-8: The World Market for Hospital Infection Diagnostics (Top 9 Leading Suppliers vs.Others) 2010CHAPTER FOUR: TREATING HOSPITAL INFECTIONSTable 4-1: Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)Table 4-3: Recent Approvals for Hospital Infection TreatmentsTable 4-5: The World Market for Hospital Infection Treatment 2005-2015Figure 4-3: The World Market for Hospital Infection Treatment Estimated Market Share byRegion, 2010CHAPTER FIVE: MARKET SUMMARYTable 5-1: The Global Market for Hospital Infections by Product Segment, 2005-2015Figure 5-1: The Global Market for Hospital Infection Products 2005-2015Figure 5-2: The Global Market for Hospital Infection Products by Product Segment, 2010(Diagnostics, Treatment)About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004E-mail: sales@reportsnreports.comhttp://www.reportsnreports.comVisit our Market Research Blog

×